Form 8-K - Current report:
SEC Accession No. 0001193125-25-123366
Filing Date
2025-05-21
Accepted
2025-05-20 20:15:42
Documents
15
Period of Report
2025-05-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d933207d8k.htm   iXBRL 8-K 31031
2 EX-10.2 d933207dex102.htm EX-10.2 34235
3 EX-10.3 d933207dex103.htm EX-10.3 18248
4 EX-10.4 d933207dex104.htm EX-10.4 17940
  Complete submission text file 0001193125-25-123366.txt   234640

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250520.xsd EX-101.SCH 2520
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250520_lab.xml EX-101.LAB 17912
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250520_pre.xml EX-101.PRE 11230
18 EXTRACTED XBRL INSTANCE DOCUMENT d933207d8k_htm.xml XML 3751
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 25970615
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)